A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer

2011160 citationsJournal Article

Authors

Good health and well-being

Published in: Annals of Oncology

Volume 23, Issue 4, pp. 968-973

Field-Weighted Citation Impact: 6.24